Effect of Intrinsic and Extrinsic Factors on the Clinical Pharmacokinetics and Pharmacodynamics of Prasugrel
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2010 |
|---|---|
| Erschienen: |
2010 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:49 |
|---|---|
| Enthalten in: |
Clinical pharmacokinetics - 49(2010), 12 vom: Dez., Seite 777-798 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Small, David S. [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Themen: |
Clopidogrel |
|---|
| doi: |
10.2165/11537820-000000000-00000 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC2037629613 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC2037629613 | ||
| 003 | DE-627 | ||
| 005 | 20230507082557.0 | ||
| 007 | tu | ||
| 008 | 200819s2010 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.2165/11537820-000000000-00000 |2 doi | |
| 035 | |a (DE-627)OLC2037629613 | ||
| 035 | |a (DE-He213)11537820-000000000-00000-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Small, David S. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Effect of Intrinsic and Extrinsic Factors on the Clinical Pharmacokinetics and Pharmacodynamics of Prasugrel |
| 264 | 1 | |c 2010 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 650 | 4 | |a Percutaneous Coronary Intervention |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Clopidogrel |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Maintenance Dose |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Lansoprazole |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Ticlopidine |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Farid, Nagy A. |e verfasserin |4 aut | |
| 700 | 1 | |a Payne, Christopher D. |e verfasserin |4 aut | |
| 700 | 1 | |a Konkoy, Christopher S. |e verfasserin |4 aut | |
| 700 | 1 | |a Jakubowski, Joseph A. |e verfasserin |4 aut | |
| 700 | 1 | |a Winters, Kenneth J. |e verfasserin |4 aut | |
| 700 | 1 | |a Salazar, Daniel E. |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical pharmacokinetics |d [Heidelberg] : Springer, 1976 |g 49(2010), 12 vom: Dez., Seite 777-798 |w (DE-627)129450995 |w (DE-600)197627-8 |w (DE-576)014816253 |x 0312-5963 |7 nnns |
| 773 | 1 | 8 | |g volume:49 |g year:2010 |g number:12 |g month:12 |g pages:777-798 |
| 856 | 4 | 1 | |u https://doi.org/10.2165/11537820-000000000-00000 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a GBV_ILN_2006 | ||
| 912 | |a GBV_ILN_2010 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4219 | ||
| 951 | |a AR | ||
| 952 | |d 49 |j 2010 |e 12 |c 12 |h 777-798 | ||